Navigation Links
Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms
Date:3/23/2009

CINCINNATI March 23, 2009 A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS, including abdominal pain, bloating and bowel movement difficulty. Bifidobacterium infantis 35624 is marketed as Bifantis® and can be found in a daily probiotic supplement by Procter & Gamble. The researchers reviewed 16 random-controlled-studies, evaluating the efficacy, safety and tolerability of probiotics in the treatment of IBS. With the exception of the Bifidobacterium infantis 35624 studies, researchers found the other trials did not use an appropriate study design and did not adequately report adverse events. The article was published on the American Journal of Gastroenterology website in advance of appearing in the publication's April 2009 issue1.

Irritable Bowel Syndrome affects one in five Americans and treatment options are limited. Darren. M Brenner, Division of Gastroenterology and Department of Internal Medicine, at Northwestern University and lead investigator of this study, hypothesized that alterations in gut microflora may contribute to the development of IBS symptoms, and believed these symptoms could be improved by probiotics. "Probiotics are gaining popularity for the treatment of multiple gastrointestinal disorders, including IBS," said Brenner, MD. "After assessment of the methodological and statistical designs of these studies, B. infantis 35624 was the only probiotic that showed repeated efficacy."

Clinical evidence and support for Bifantis continues to grow

Bifidobacterium infantis 35624, discovered in the early 1990s by microbiologists at Alimentary Health in Cork, Ir
'/>"/>

Contact: Chido Tsemunhu
Chido.Tsemunhu@mslworldwide.com
212-468-3681
Manning Selvage & Lee
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stanford researchers publish review of US medical device regulation
2. Medicines derived from cannabis: a review of adverse events
3. Review article provides tools for the Rosaceae genomics community
4. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
5. Experts discuss applying systematic review to the field of nutrition
6. Biophysical Reviews makes debut in 2009
7. A re-review of peer review: Leading journal looks to end the review nightmare
8. Swedish university honors probiotics scientist
9. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
10. Vitamin E trials fatally flawed
11. Research team says extraterrestrial impact to blame for Ice Age extinctions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... better identify and treat those with fibromuscular dysplasia (FMD). ... sized arteries in the body, which can restrict blood flow ... new report appearing in August 2014 issue of ... FMD may not be limited to the arteries as currently ... bones and joints, as well as evidence that inflammation may ...
(Date:7/31/2014)... Fire was in full fury, raging swiftly from crown ... backcountry of Yosemite National Park in California,s Sierra Nevada ... battle began to turn, enacting a case study in ... fuel large, severe fires. , "When the Rim Fire ... had been used as a management tool, rather than ...
(Date:7/31/2014)... are familiar with Hibiscus flowers- they are an ... are commonly planted in the landscape. Some, like ... endangered species. , Only a relatively few botanists ... an equally beautiful and intriguing related group of ... of Hibiscus". , Brother of Hibiscus species are ...
Breaking Biology News(10 mins):Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5Brother of Hibiscus is found alive and well on Maui 2
... and how that impacts on their weight gain has been the ... Researchers in the University,s Robinson Institute and the ... women to better understand the links between body image and excessive ... Women and Birth , show that more than ...
... Today at the Beyond the Genome conference in San ... BioMed Central Open Data Award for their work demonstrating ... Trichinella spiralis , a human pathogen. Presented by the ... have demonstrated leadership in the sharing, standardization, publication, or ...
... /PRNewswire-iReach/ -- Clinilabs, a contract research organization that provides ... announced today that they have begun a Phase I ... 2 Diabetes Mellitus.  The study is being conducted to ... of the investigational medication over periods of up to ...
Cached Biology News:Body image impacts on weight gain during pregnancy 2BGI scientists win BioMed Central Open Data Award 2Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication 2
(Date:7/31/2014)... “Rapid technological advances will spread ... increasing unemployment, depressing American consumer spending and further ... Catch 22—we need automated manufacturing if we are ... says economist and corporate relocation expert Dr. Ron ... Pro-Business States for 2014, co-published with the American ...
(Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, LLC ... stem cell biotechnologies. Currently the company holds seven ... patent applications currently under examination by the U.S. Patent ... of the most vexing problems in adult stem cell ... are difficult to identify; and they have been difficult ...
(Date:7/30/2014)... W. R. Grace & Co. (NYSE: ... REVELERIS® Prep purification system , a dual-mode instrument ... researchers to perform both flash and preparative liquid ... the REVELERIS® Prep purification system, researchers can easily ... a simple touch of the screen, giving them ...
(Date:7/30/2014)... 30, 2014  Replikins Ltd. today released new data ... virus. Before the current outbreaks, the mean Ebola Reston ... acids) between 1995 and 2002 was 1.1; the mean ... and sixteen-fold in 2013, thus predicting the current outbreaks ... has been shown to be able to predict outbreaks ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Grace Launches New REVELERIS® Prep Purification System 2
... ... ... ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... BioSpain 2010 -- MADRID, October 22, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... flu is already tough, but it has become even harder in ... two antiviral drugs don,t slow it down anymore. Reporting their ... and Brigham Young move closer to understanding why not, and how ... changes. The two drugs, amantadine and rimantadine, are no longer ...
Cached Biology Technology:OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering 9700 Companies With 1.400 Participants Attend BioSpain 2010 2700 Companies With 1.400 Participants Attend BioSpain 2010 3700 Companies With 1.400 Participants Attend BioSpain 2010 4700 Companies With 1.400 Participants Attend BioSpain 2010 5700 Companies With 1.400 Participants Attend BioSpain 2010 6700 Companies With 1.400 Participants Attend BioSpain 2010 7Putting a bull's-eye on the flu: Detailing influenza's structure for drug targeting 2
... STag Purification Kits enable rapid analytical to ... proteins produced from appropriate vectors. Sufficient reagents ... 1 mg target protein under native or ... S-protein Agarose, which specifically retains STag fusion ...
... Group combines deep experience, skills and flexibility ... collaborative team chemistry. This combination enables optimum ... and beyond.,With AAIBiotech, you can count on ... more than that: its the power of ...
S-100 alpha/beta chain (8B10)...
... number is a new product number, ... number. If showing no availability yet, ... number (Z71,487-9) or contact customer service ... neck 100 mm, No. of sidearm ...
Biology Products: